Philip Morris International — the manufacturer of Marlboro cigarettes for the United Kingdom — is attempting to purchase Vectura, a pharmaceutical company that produces asthma inhalers.
In order to parry another buyout offer from American private equity firm Carlyle, Philip Morris International increased its bid to $2.29 per share, giving Vectura a $1.4 billion valuation.
.png)
.png)
